Research Nottingham

Research Nottingham

Share

We are Research & Innovation at Nottingham University Hospitals NHS Trust

22/09/2026

How are bispecific antibodies changing blood cancer treatment?🩸 🤔

Professor Chris Fox, Consultant Haematologist at Nottingham University Hospitals, explains how these innovative treatments work by helping the body’s own immune system target cancer cells 🔬

He also discusses Nottingham’s involvement in major clinical trials, including the STARGLO study, and how ongoing research could help improve treatment options, survival and quality of life for patients in the future 🙌

🎥 Watch the video to find out more 👇

20/09/2026

A pioneering cancer treatment at NUH has saved a Forces veteran’s life

Our research into pioneering new treatment combinations for blood cancer is saving lives - including that of a veteran aircraft engineer with 30 years’ RAF service.

Nottingham University Hospitals NHS Trust played a leading role in a clinical trial investigated a new treatment to fight the most aggressive type of non-Hodgkin lymphoma.

Former RAF engineer Tim Swinburn, from Derbyshire, was among the first to benefit. In our video, Tim, a keen motorcyclist, explains the massive difference the research and clinical care he received has made to him.

17/09/2026

Missed RehabTech Together 2026? 🚨

You can now catch up on the full event online 🎥

Hear from researchers, clinicians, innovators and people with lived experience as they explore the latest developments shaping the future of rehabilitation technology 🔬

Watch the full event here 👉 https://www.youtube.com/live/8jaEtmmdPYQ?si=P4rzbE4MO0VXFff6

16/09/2026

We’re live! 🔴

Join us now for RehabTech Together 2026, bringing together researchers, clinicians, innovators and people with lived experience to explore the future of rehabilitation technology.

Watch live on YouTube and be part of the conversation 👇

https://youtube.com/live/8jaEtmmdPYQ?feature=share

11/09/2026

Could a weight-loss drug help tackle alcohol dependence and obesity at the same time? 🤔

A new £2.7 million UK study is investigating whether semaglutide, also known as Wegovy, could help people living with alcohol dependence, obesity and liver disease🔬

The CURB trial will recruit 268 people across England, Wales and Scotland, with researchers exploring whether the treatment can reduce alcohol use, support weight loss and improve liver health.

🎥 Watch the video to hear more about this important research.

Photos from Research Nottingham's post 09/09/2026

Yesterday was a really special day as we came together to celebrate 20 years of the NIHR in the East Midlands 🎉

It was a chance to look back at everything that has been achieved over the past two decades, but just as importantly, to spend time together, share ideas and make new connections 🙌

Days like this are extremely important. They bring people together, keep us joined up and connected, and most importantly help us keep moving research forward for our patients 🔬

There was a real sense throughout the day of how much exciting work is happening across the region, from the research being shared through the poster presentations to the conversations happening between colleagues 📝

Research moves forward when people come together, share what they know and find new ways to work with each other 👏

Thank you to everyone who joined us and made the day what it was. We’re proud of what has been achieved so far, and excited to see what the next 20 years will bring 🌟

Photos from Research Nottingham's post 08/09/2026

We kicked off the afternoon proceedings here at Trent Vinyard for the event with a stirring performance from the Singing from the Soul choir.

Research colleagues from Nottingham, including from our NIHR BRC and CRF, are gathered together with partners from around the NIHR infrastructure across the East Midlands region including Leicestershire and Lincolnshire to celebrate 20 years of the NIHR at a conference today.

The choir was introduced by Professor Stephen Ryder, Director of our NIHR Clinical Research Facility in Nottingham.

We've been recognising two decades of life-changing health and care research, and to look ahead to the future.

Photos from Research Nottingham's post 08/09/2026

We're joining colleagues from across the East Midlands today at Trent Vinyard Conference Centre in Nottingham to celebrate how research is not just adding years to the life of patients but adding life to years.

Colleagues from the NHS, academia, industry and public contributors from around the region are celebrating the difference the NIHR has made to transforming patients' outcomes over the last 20 years.

Photos from Research Nottingham's post 08/09/2026

We’re excited to be celebrating 20 years of the NIHR in the East Midlands today! 🎉

People are starting to arrive as we bring together colleagues from across the region’s research community to celebrate two decades of health and care research and the difference it has made to people’s lives.

Today will feature inspiring speakers, interactive masterclasses, research poster presentations and plenty of opportunities to connect and share ideas.

A brilliant opportunity to come together as One NIHR, look back at what has been achieved over the last 20 years and look ahead to the future of research in the East Midlands.

We’ll be sharing more from the day as it happens. 📸

Photos from Research Nottingham's post 25/08/2026

Our liver research experts in the spotlight over £2.7 million national research programme using weight loss drug

Researchers at our NIHR Biomedical Research Centre (BRC) in Nottingham are working with experts in Plymouth to find out whether a popular weight loss drug can help patients with alcohol dependency and obesity - two of the biggest causes of liver disease.

The CURB research trial is a £2.7 million national funded research programme to investigate whether a weight-loss injection (semaglutide, also known as Wegovy) can help patients living with alcohol dependency and obesity, two of the biggest causes of liver disease.

The story about this research has been catching the attention of the media. Professor Guru Aithal, Co-Lead of the CURB trial and Deputy Director of the NIHR BRC in Nottingham, was recently interviewed by BBC East Midlands TV.

This research was also the subject of a BBC News online story: https://www.bbc.co.uk/news/articles/c9q98n241g5o

Professor Aithal was also a guest on Verity Cowley’s BBC Radio Nottingham show. He discussed the urgent need for new treatments for alcohol dependency, obesity and liver disease.

His interview is on the BBC Sounds App and can be accessed via the link below, starting around 1 hour 14 minutes into the show, and finishing at approximately 1 hour 21 minutes

https://www.bbc.co.uk/sounds/play/m00308cx

Want your university to be the top-listed University in Nottingham?
Click here to claim your Sponsored Listing.

Telephone

Address


Queens Medical Centre
Nottingham
NG72UH